JP2021113172A - Peptidyl arginine deiminase 1 expression promoter - Google Patents
Peptidyl arginine deiminase 1 expression promoter Download PDFInfo
- Publication number
- JP2021113172A JP2021113172A JP2020006711A JP2020006711A JP2021113172A JP 2021113172 A JP2021113172 A JP 2021113172A JP 2020006711 A JP2020006711 A JP 2020006711A JP 2020006711 A JP2020006711 A JP 2020006711A JP 2021113172 A JP2021113172 A JP 2021113172A
- Authority
- JP
- Japan
- Prior art keywords
- pad1
- hair
- hair growth
- action
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101001114059 Homo sapiens Protein-arginine deiminase type-1 Proteins 0.000 title claims abstract description 45
- 102100023222 Protein-arginine deiminase type-1 Human genes 0.000 title claims abstract description 45
- 230000014509 gene expression Effects 0.000 title claims abstract description 38
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 82
- 241000508269 Psidium Species 0.000 claims abstract description 69
- 230000003779 hair growth Effects 0.000 claims abstract description 48
- 235000007119 Ananas comosus Nutrition 0.000 claims abstract description 43
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 43
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 25
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 21
- 230000001737 promoting effect Effects 0.000 claims abstract description 16
- 239000004909 Moisturizer Substances 0.000 claims abstract description 7
- 230000001333 moisturizer Effects 0.000 claims abstract description 7
- 235000013305 food Nutrition 0.000 claims abstract description 6
- 244000099147 Ananas comosus Species 0.000 claims abstract 2
- 240000006432 Carica papaya Species 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims description 12
- 210000004209 hair Anatomy 0.000 abstract description 34
- 230000009471 action Effects 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 description 47
- 241000234671 Ananas Species 0.000 description 42
- 241000219173 Carica Species 0.000 description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
- 239000000469 ethanolic extract Substances 0.000 description 30
- 101000590281 Homo sapiens 26S proteasome non-ATPase regulatory subunit 14 Proteins 0.000 description 29
- 239000008187 granular material Substances 0.000 description 25
- 239000000284 extract Substances 0.000 description 17
- 230000035622 drinking Effects 0.000 description 16
- 239000004615 ingredient Substances 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 102100026263 Sphingomyelin phosphodiesterase Human genes 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 5
- 235000013734 beta-carotene Nutrition 0.000 description 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 5
- 239000011648 beta-carotene Substances 0.000 description 5
- 229960002747 betacarotene Drugs 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 5
- 102100024005 Acid ceramidase Human genes 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 101000975753 Homo sapiens Acid ceramidase Proteins 0.000 description 4
- 101000785978 Homo sapiens Sphingomyelin phosphodiesterase Proteins 0.000 description 4
- 108010076876 Keratins Proteins 0.000 description 4
- 102000011782 Keratins Human genes 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 210000003780 hair follicle Anatomy 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000010195 expression analysis Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 102000001235 protein arginine deiminase Human genes 0.000 description 3
- 108060006632 protein arginine deiminase Proteins 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000219172 Caricaceae Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 101710201924 Sphingomyelin phosphodiesterase 1 Proteins 0.000 description 2
- 101710095280 Sphingomyelinase C 1 Proteins 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 101000894568 Catharanthus roseus Catharanthine synthase Proteins 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000000940 FEMA 2235 Substances 0.000 description 1
- 102100028314 Filaggrin Human genes 0.000 description 1
- 101710088660 Filaggrin Proteins 0.000 description 1
- 108700041153 Filaggrin Proteins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000048298 Inga vera Species 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical group NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- 241000219926 Myrtaceae Species 0.000 description 1
- BLTCBVOJNNKFKC-QUDYQQOWSA-N N-acetylsphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(C)=O BLTCBVOJNNKFKC-QUDYQQOWSA-N 0.000 description 1
- -1 N-acetylsphingosine amide Chemical class 0.000 description 1
- 101150108558 PAD1 gene Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010048218 Xeroderma Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003778 catagen phase Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000004919 hair shaft Anatomy 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000004918 root sheath Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Abstract
Description
本発明は、グァバ葉を含有することを特徴とするペプチジルアルギニンデイミナーゼ1発現促進剤、保湿剤、発毛剤及び育毛剤に関する。さらに詳しくは、グァバ葉、パイナップル果実及びパパイヤ果実を含有することを特徴とするペプチジルアルギニンデイミナーゼ1発現促進剤、保湿剤、発毛剤及び育毛剤に関する。 The present invention relates to a peptidyl arginine deiminase 1 expression promoter, a moisturizer, a hair growth agent and a hair growth agent, which are characterized by containing guava leaves. More specifically, the present invention relates to a peptidyl arginine deiminase 1 expression promoter, a moisturizer, a hair growth agent and a hair growth agent, which are characterized by containing guava leaves, pineapple fruits and papaya fruits.
ペプチジルアルギニンデイミナーゼ(PAD、peptidylarginine deiminase)はペプチド中の塩基性アミノ酸であるアルギニン残基をシトルリン残基に変換する翻訳後修飾酵素である。PADアイソフォームの一つであるPAD1は、ヒトの表皮や毛包の分化に重要な因子である(非特許文献1)。 Peptidylarginine deiminase (PAD) is a post-translational modification enzyme that converts arginine residues, which are basic amino acids in peptides, into citrulline residues. PAD1, which is one of the PAD isoforms, is an important factor for the differentiation of human epidermis and hair follicles (Non-Patent Document 1).
皮膚の保湿機能は角質層が担っている。角質層が皮膚内部の水分を逃さず一定に保つためには、天然保湿因子(NMF、natural moisturizing factor)が充分にあることが重要である。表皮の角化過程において、プロフィラグリンから遊離されたフィラグリンが、PAD1による修飾を受けることでNMFは産生される。このように、PAD1はNMF産生に必須の因子であり、皮膚の保湿機能の維持亢進において重要な役割を果たしている。 The stratum corneum is responsible for the moisturizing function of the skin. In order for the stratum corneum to keep the moisture inside the skin constant without escaping, it is important that there is a sufficient amount of natural moisturizing factors (NMF, natural moisturizing factor). In the process of keratinization of the epidermis, NMF is produced by modifying filaggrin released from profilaggrin with PAD1. As described above, PAD1 is an essential factor for NMF production and plays an important role in maintaining and enhancing the moisturizing function of the skin.
毛包は、毛、毛根鞘、毛母細胞、毛乳頭細胞などで形成される毛を産生する器官である。毛は、成長期、退行期、休止期、脱毛期からなる周期をもって毛の伸長と脱毛を繰り返している。成長期は、毛包が分化して成長する期間であり、毛根が頻繁に分裂し毛幹に付け加わることで毛が伸長していく。この毛包の分化に係るPAD1は、毛の発生と伸長において重要な役割を果たしている。 Hair follicles are organs that produce hair formed by hair, root sheaths, hair matrix cells, hair papilla cells, and the like. Hair grows and loses hair repeatedly in a cycle consisting of a growth phase, a catagen phase, a resting phase, and a hair loss phase. The growth period is a period in which hair follicles differentiate and grow, and hair grows by frequently dividing hair roots and adding them to the hair shaft. PAD1 related to the differentiation of hair follicles plays an important role in hair development and elongation.
真珠および/または貝殻に含まれる水不溶性タンパク質の酵素分解物を有効成分とするPAD1産生促進剤(特許文献1)はあるが、形態は皮膚外用剤である。また、グァバ葉、パイナップル果実又はパパイヤ果実を含有する保湿用化粧料などはあるが、これら3種の併用による保湿作用や発毛及び育毛作用に関する知見は一切なく、それに係る発明も未だにない。 There is a PAD1 production promoter (Patent Document 1) containing an enzymatically decomposed product of a water-insoluble protein contained in pearls and / or shells as an active ingredient, but the form is an external preparation for skin. In addition, although there are moisturizing cosmetics containing guava leaves, pineapple fruits, or papaya fruits, there is no knowledge about the moisturizing effect, hair growth, and hair growth effect of these three types in combination, and there is no invention related thereto.
本発明は、グァバ葉を含有することを特徴とするPAD1発現促進剤、保湿剤、発毛剤及び育毛剤に関する。さらに詳しくは、グァバ葉、パイナップル果実及びパパイヤ果実を含有することを特徴とするPAD1発現促進剤、保湿剤、発毛剤及び育毛剤に関する。 The present invention relates to a PAD1 expression promoter, a moisturizer, a hair growth agent and a hair growth agent, which are characterized by containing guava leaves. More specifically, the present invention relates to a PAD1 expression promoter, a moisturizer, a hair growth agent and a hair growth agent, which are characterized by containing guava leaves, pineapple fruits and papaya fruits.
本発明者らは、鋭意研究した結果、グァバ葉がPAD1発現促進作用、保湿作用、発毛及び育毛作用を有することを見出した。さらに、グァバ葉、パイナップル果実、パパイヤ果実の併用により、PAD1発現促進作用、保湿作用、発毛及び育毛作用が顕著に増加することを見出した。 As a result of diligent research, the present inventors have found that guava leaves have a PAD1 expression promoting action, a moisturizing action, a hair growth and a hair growth action. Furthermore, it was found that the combined use of guava leaves, pineapple fruits, and papaya fruits significantly increases the PAD1 expression promoting action, moisturizing action, hair growth and hair growth action.
本発明のグァバ葉として、フトモモ科(Myrtaies)バンジロウ属(Psidium)に属するグァバ(Psidium guajava)の葉を用いることができる。 As the guava leaf of the present invention, a leaf of guava (Psidium guava) belonging to the genus Guava (Psidium) of the Myrtaceae family can be used.
本発明のパイナップル果実として、パイナップル科(Bromeliaceae)アナナス属(Ananas)に属するパイナップル(Ananas comosus)の果実を用いることができる。 As the pineapple fruit of the present invention, a fruit of the pineapple (Ananas comosos) belonging to the genus Bromeliad (Bromeliad) Bromeliad can be used.
本発明のパパイヤ果実として、パパイヤ科(Caricaceae)パパイヤ属(Carica)に属するパパイヤ(Carica papaya)の果実を用いることができる。 As the papaya fruit of the present invention, a fruit of papaya (Calica papaya) belonging to the genus Papaya (Caricaceae) of the family Caricaceae can be used.
本発明に用いるグァバ葉、パイナップル果実、パパイヤ果実は、必要に応じてそのままの状態、破砕物、圧搾物、乾燥物などを適宜選択することができる。また、微粒化処理、ロールプレス処理、摩砕処理、超高圧マイクロスチーム処理、通常工業的に用いられるその他機械的方法などで処理して用いてもよい。 As the guava leaf, pineapple fruit, papaya fruit used in the present invention, the state as it is, a crushed product, a pressed product, a dried product, or the like can be appropriately selected as needed. Further, it may be treated by atomization treatment, roll press treatment, grinding treatment, ultra-high pressure microsteam treatment, or other mechanical method usually used industrially.
本発明に用いるグァバ葉、パイナップル果実、パパイヤ果実は、必要に応じて抽出操作に付することができる。抽出溶媒として、水、低級アルコール類(メタノール、エタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノールなど)、液状多価アルコール類(1,3−ブチレングリコール、プロピレングリコール、グリセリンなど)、ケトン類(アセトン、メチルエチルケトンなど)、アセトニトリル、エステル類(酢酸エチル、酢酸ブチルなど)、炭化水素類(ヘキサン、ヘプタン、石油エーテルなど)、エーテル類(エチルエーテル、テトラヒドロフラン、プロピルエーテルなど)などを用いることができる。これらの溶媒は一種でも二種以上を混合して用いても良い。また、抽出方法としては、連続抽出、浸漬抽出などが挙げられ、必要に応じて、濃縮、希釈、濾過、活性炭処理などによる脱色、脱臭などの処理をして用いてもよい。更には、抽出した溶液を濃縮乾固、噴霧乾燥、凍結乾燥などの処理を行い、乾燥物として用いてもよい。 The guava leaves, pineapple fruits, and papaya fruits used in the present invention can be subjected to an extraction operation as needed. As extraction solvent, water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohols (1,3-butylene glycol, propylene glycol, glycerin, etc.) ), Ketones (acetone, methyl ethyl ketone, etc.), acetonitrile, esters (ethyl acetate, butyl acetate, etc.), hydrocarbons (hexane, heptane, petroleum ether, etc.), ethers (ethyl ether, tetrahydrofuran, propyl ether, etc.), etc. Can be used. These solvents may be used alone or in admixture of two or more. Further, examples of the extraction method include continuous extraction, immersion extraction and the like, and if necessary, treatments such as concentration, dilution, filtration, decolorization by activated carbon treatment and the like, and deodorization may be performed. Further, the extracted solution may be subjected to treatments such as concentrated drying, spray drying, freeze drying and the like, and used as a dried product.
本発明のグァバ葉、パイナップル果実、パパイヤ果実は、いずれの処理物あるいは抽出物を用いてもよい。更に、グァバ葉は含水エタノール抽出物、パイナップル果実はエタノール抽出物、パパイヤ果実は乾燥破砕した粉末を用いることが好ましい。 Any processed product or extract may be used for the guava leaf, pineapple fruit, and papaya fruit of the present invention. Further, it is preferable to use a hydrous ethanol extract for guava leaves, an ethanol extract for pineapple fruits, and a dry and crushed powder for papaya fruits.
本発明に用いるグァバ葉、パイナップル果実、パパイヤ果実の摂取量は、投与形態、使用目的、年齢、体重などによって異なる。グァバ葉含水エタノール抽出物として0.1〜100mg/日、好ましくは0.5〜20mg/日、より好ましくは1〜10mg/日の範囲で1日1回から数回経口投与できる。パイナップル果実エタノール抽出物として1〜1000mg/日、好ましくは10〜100mg/日、より好ましくは20〜50mg/日の範囲で1日1回から数回経口投与できる。パパイヤ果実粉末として0.1〜100mg/日、好ましくは0.5〜20mg/日、より好ましくは1〜10mg/日の範囲で1日1回から数回経口投与できる。上記投与範囲より少ない量で十分な場合もあるし、また、範囲を超えて投与する必要がある場合もある。また、製剤化における薬効成分の添加法については、予め加えておいても、製造途中で添加しても良く、作業性を考えて適宜選択すれば良い。 The intake of guava leaves, pineapple fruits, and papaya fruits used in the present invention varies depending on the dosage form, purpose of use, age, body weight, and the like. The guava leaf hydrous ethanol extract can be orally administered once to several times a day in the range of 0.1 to 100 mg / day, preferably 0.5 to 20 mg / day, more preferably 1 to 10 mg / day. The pineapple fruit ethanol extract can be orally administered once to several times a day in the range of 1 to 1000 mg / day, preferably 10 to 100 mg / day, more preferably 20 to 50 mg / day. As papaya fruit powder, it can be orally administered once to several times a day in the range of 0.1 to 100 mg / day, preferably 0.5 to 20 mg / day, more preferably 1 to 10 mg / day. In some cases, an amount smaller than the above-mentioned administration range may be sufficient, and in other cases, it may be necessary to administer beyond the above-mentioned administration range. Further, the method of adding the medicinal ingredient in the formulation may be added in advance or may be added during the production, and may be appropriately selected in consideration of workability.
本発明のPAD1発現促進剤は、食品、医薬部外品又は医薬品のいずれにも用いることができる。その剤形は内服用であることが好ましく、散剤、顆粒剤、錠剤、糖衣錠剤、カプセル剤、シロップ剤、丸剤、懸濁剤、液剤、乳剤などの剤形で用いることができる。また、皮膚外用剤、注射剤、座剤などとして用いることもできる。 The PAD1 expression promoter of the present invention can be used for any of foods, quasi-drugs or pharmaceuticals. The dosage form is preferably taken internally, and can be used in dosage forms such as powders, granules, tablets, sugar-coated tablets, capsules, syrups, pills, suspensions, liquids and emulsions. It can also be used as an external preparation for skin, an injection, a suppository, and the like.
本発明のPAD1発現促進剤は、効果を損なわない範囲内で、必要に応じて通常の食品、医薬部外品又は医薬品に用いられる賦形剤、安定剤、保存剤、結合剤、崩壊剤、炭化水素類、脂肪酸類、ビタミン類、アルコール類、エステル類、pH調整剤、防腐剤、香料などの成分を含有することもできる。ビタミン類を含有することが好ましく、更にβ―カロテン(ビタミンA)、ビタミンC、ビタミンEを含有することが好ましく、特にβ―カロテンを1〜2mg、ビタミンCを1000〜2000mg、ビタミンEを10〜20mgで含有することが好ましい。 The PAD1 expression-promoting agent of the present invention is an excipient, a stabilizer, a preservative, a binder, a disintegrant, which is used for ordinary foods, non-pharmaceutical products or pharmaceuticals, as necessary, as long as the effect is not impaired. It can also contain components such as hydrocarbons, fatty acids, vitamins, alcohols, esters, pH regulators, preservatives and fragrances. It preferably contains vitamins, and more preferably β-carotene (vitamin A), vitamin C, and vitamin E, especially β-carotene (1-2 mg), vitamin C (1000-2000 mg), and vitamin E (10). It is preferably contained in an amount of ~ 20 mg.
本発明における保湿剤は、皮膚中の水分量を増加させ、皮膚からの水分蒸散量を抑制する剤であり、乾燥肌、乾皮症、皮脂欠乏症、シワ、アトピー性皮膚炎、肌荒れ、角化異常を予防、改善することができる。 The moisturizer in the present invention is an agent that increases the amount of water in the skin and suppresses the amount of water evaporation from the skin, and is used for dry skin, xeroderma, sebum deficiency, wrinkles, atopic dermatitis, rough skin, and keratinization. Abnormalities can be prevented and ameliorated.
本発明における発毛剤及び育毛剤は、頭髪などの毛の発生と伸長を促す剤であり、増毛や薄毛及び脱毛の予防改善をすることができる。 The hair growth agent and hair growth agent in the present invention are agents that promote the growth and elongation of hair such as hair, and can prevent and improve hair thickening, thinning hair, and hair loss.
本発明のグァバ葉を含有することを特徴とするPAD1発現促進剤は、PAD1発現促進作用、保湿作用、発毛及び育毛作用を有する。さらに、グァバ葉、パイナップル果実及びパパイヤ果実を含有することを特徴とするPAD1発現促進剤は、優れたPAD1発現促進作用、保湿作用、発毛及び育毛作用を有する。 The PAD1 expression-promoting agent characterized by containing the guava leaf of the present invention has a PAD1 expression-promoting action, a moisturizing action, a hair growth and a hair growth action. Furthermore, the PAD1 expression-promoting agent, which is characterized by containing guava leaves, pineapple fruits and papaya fruits, has an excellent PAD1 expression-promoting action, a moisturizing action, a hair growth and a hair-growth action.
以下の実施例は例示のために説明するものであり、本発明の特許請求の範囲はこれらの実施例により何ら限定されるものではない。尚、実施例に示す含有量の%は重量%を示す。 The following examples are provided for illustration purposes only, and the scope of claims of the present invention is not limited to these examples. In addition,% of the content shown in an Example shows weight%.
製造例1 グァバ葉熱水抽出物
グァバ葉100gに、精製水2Lを加え、95〜100℃で2時間抽出した後、濾液を濃縮、凍結乾燥して、グァバ葉熱水抽出物9.3gを得た。
Production Example 1 Guava leaf hot water extract Add 2 L of purified water to 100 g of guava leaf, extract at 95-100 ° C. for 2 hours, concentrate the filtrate, freeze-dry, and add 9.3 g of guava leaf hot water extract. Obtained.
製造例2 グァバ葉30%エタノール抽出物
グァバ葉100gに、精製水1.4Lとエタノール0.6Lを加え、常温で5日間抽出した後、濾液を濃縮乾固して、グァバ葉30%エタノール抽出物5.7gを得た。
Production Example 2 Guava leaf 30% ethanol extract Add 1.4 L of purified water and 0.6 L of ethanol to 100 g of guava leaf, extract at room temperature for 5 days, then concentrate and dry the filtrate to extract 30% ethanol of guava leaf. 5.7 g of the product was obtained.
製造例3 グァバ葉70%エタノール抽出物
グァバ葉100gに、精製水0.6Lとエタノール1.4Lを加え、常温で5日間抽出した後、濾液を濃縮乾固して、グァバ葉70%エタノール抽出物3.2gを得た。
Production Example 3 Guava leaf 70% ethanol extract Add 0.6 L of purified water and 1.4 L of ethanol to 100 g of guava leaf, extract at room temperature for 5 days, concentrate and dry the filtrate, and extract 70% ethanol of guava leaf. 3.2 g of the product was obtained.
製造例4 パイナップル熱水抽出物
パイナップル果実100gに、精製水2Lを加え、95〜100℃で2時間抽出した後、濾液を濃縮、凍結乾燥して、パイナップル果実熱水抽出物7.4gを得た。
Production Example 4 Pineapple Hot Water Extract Add 2 L of purified water to 100 g of pineapple fruit, extract at 95-100 ° C for 2 hours, concentrate the filtrate and freeze-dry to obtain 7.4 g of pineapple fruit hot water extract. rice field.
製造例5 パイナップル果実30%エタノール抽出物
パイナップル果実100gに、精製水1.4Lとエタノール0.6Lを加え、常温で5日間抽出した後、濾液を濃縮乾固して、パイナップル果実30%エタノール抽出物4.0gを得た。
Production Example 5 Pineapple fruit 30% ethanol extract Add 1.4 L of purified water and 0.6 L of ethanol to 100 g of pineapple fruit, extract at room temperature for 5 days, then concentrate and dry the filtrate to extract 30% ethanol of pineapple fruit. 4.0 g of the product was obtained.
製造例6 パイナップル果実エタノール抽出物
パイナップル果実100gに、エタノール1Lを加え、常温で5日間抽出した後、濾液を濃縮乾固して、パイナップル果実エタノール抽出物4.1gを得た。
Production Example 6 Pineapple Fruit Ethanol Extract To 100 g of pineapple fruit, 1 L of ethanol was added, and the mixture was extracted at room temperature for 5 days, and then the filtrate was concentrated to dryness to obtain 4.1 g of pineapple fruit ethanol extract.
製造例7 パパイヤ果実粉末
パパイヤ果実100gを乾燥させ、粉砕後にふるい選別して、パパイヤ果実粉末80gを得た。
Production Example 7 Papaya fruit powder 100 g of papaya fruit was dried, pulverized and sorted by sieving to obtain 80 g of papaya fruit powder.
製造例8 パパイヤ果実熱水抽出物
パパイヤ果実100gに、精製水2Lを加え、95〜100℃で2時間抽出した後、濾液を濃縮、凍結乾燥して、パパイヤ果実熱水抽出物8.7gを得た。
Production Example 8 Papaya Fruit Hot Water Extract Add 2 L of purified water to 100 g of papaya fruit, extract at 95-100 ° C for 2 hours, concentrate the filtrate, freeze-dry, and add 8.7 g of papaya fruit hot water extract. Obtained.
製造例9 パパイヤ果実30%エタノール抽出物
パパイヤ果実100gに、精製水1.4Lとエタノール0.6Lを加え、常温で5日間抽出した後、濾液を濃縮乾固して、パパイヤ果実30%エタノール抽出物4.7gを得た。
Production Example 9 Papaya Fruit 30% Ethanol Extract To 100 g of papaya fruit, 1.4 L of purified water and 0.6 L of ethanol were added, extracted at room temperature for 5 days, and then the filtrate was concentrated to dryness to extract papaya fruit with 30% ethanol. 4.7 g of the product was obtained.
処方例1 顆粒剤
<処方>
成分 含有量(%)
1.グァバ葉30%エタノール抽出物(製造例2) 0.16
2.乳糖 91.84
3.セルロース 8.00
<製造方法>
成分1〜3を乾式法により造粒し、顆粒剤を得る。
<用法>
1日当り3.2g摂取する。
Prescription example 1 Granules <Prescription>
Ingredient content (%)
1. 1. Guava leaf 30% ethanol extract (Production Example 2) 0.16
2. Lactose 91.84
3. 3. Cellulose 8.00
<Manufacturing method>
Ingredients 1 to 3 are granulated by a dry method to obtain granules.
<Usage>
Take 3.2g per day.
処方例2 顆粒剤
<処方>
成分 含有量(%)
1.グァバ葉30%エタノール抽出物(製造例2) 0.16
2.パイナップル果実エタノール抽出物(製造例6) 1.25
3.パパイヤ果実粉末(製造例7) 0.16
4.乳糖 90.43
5.セルロース 8.00
<製造方法>
成分1〜5を乾式法により造粒し、顆粒剤を得る。
<用法>
1日当り3.2g摂取する。
Prescription example 2 Granules <Prescription>
Ingredient content (%)
1. 1. Guava leaf 30% ethanol extract (Production Example 2) 0.16
2. Pineapple Fruit Ethanol Extract (Production Example 6) 1.25
3. 3. Papaya fruit powder (Production Example 7) 0.16
4. Lactose 90.43
5. Cellulose 8.00
<Manufacturing method>
Ingredients 1 to 5 are granulated by a dry method to obtain granules.
<Usage>
Take 3.2g per day.
処方例3 顆粒剤
<処方>
成分 含有量(%)
1.グァバ葉30%エタノール抽出物(製造例2) 0.16
2.パイナップル果実エタノール抽出物(製造例6) 1.25
3.パパイヤ果実粉末(製造例7) 0.16
4.β―カロテン 0.05
5.ビタミンC 50.00
6.ビタミンE 0.50
7.乳糖 39.88
8.セルロース 8.00
<製造方法>
成分1〜8を乾式法により造粒し、顆粒剤を得る。
<用法>
1日当り3.2g摂取する。
Prescription example 3 Granules <Prescription>
Ingredient content (%)
1. 1. Guava leaf 30% ethanol extract (Production Example 2) 0.16
2. Pineapple Fruit Ethanol Extract (Production Example 6) 1.25
3. 3. Papaya fruit powder (Production Example 7) 0.16
4. β-carotene 0.05
5. Vitamin C 50.00
6. Vitamin E 0.50
7. Lactose 39.88
8. Cellulose 8.00
<Manufacturing method>
Ingredients 1 to 8 are granulated by a dry method to obtain granules.
<Usage>
Take 3.2g per day.
処方例4 軟カプセル剤
<処方>
成分 含有量(%)
1.グァバ葉熱水抽出物(製造例1) 0.090
2.パイナップル果実熱水抽出物(製造例4) 1.800
3.パパイヤ果実熱水抽出物(製造例8) 0.006
4.米胚芽油 78.104
5.ミツロウ 12.000
6.ビタミンE 8.000
<製造方法>
成分1〜6を混合し、ゼラチン、グリセリン、カラメル色素で構成される被膜に、350mg充填し、乾燥後、軟カプセル剤を得る。
<用法>
1日当り3粒摂取する。
Prescription example 4 Soft capsule <Prescription>
Ingredient content (%)
1. 1. Guava leaf hot water extract (Production Example 1) 0.090
2. Pineapple fruit hot water extract (Production Example 4) 1.800
3. 3. Papaya fruit hot water extract (Production Example 8) 0.006
4. Rice germ oil 78.104
5. Beeswax 12,000
6. Vitamin E 8,000
<Manufacturing method>
Ingredients 1 to 6 are mixed, 350 mg is filled in a film composed of gelatin, glycerin, and caramel color, and after drying, a soft capsule is obtained.
<Usage>
Take 3 tablets per day.
処方例5 飲料
<処方>
成分 含有量(%)
1.グァバ葉70%エタノール抽出物(製造例3) 0.10
2.パイナップル果実30%エタノール抽出物(製造例5) 1.80
3.パパイヤ果実30%エタノール抽出物(製造例9) 0.01
4.クエン酸 6.00
5.ショ糖 11.00
6.香料 1.00
7.水 80.09
<製造方法>
成分1〜6を成分7の一部の水に撹拌溶解する。次いで、成分7の残りの水を加えて混合し、殺菌したものを飲料とする。
<用法>
1日当り50mL摂取する。
Prescription example 5 Beverage <Prescription>
Ingredient content (%)
1. 1. Guava leaf 70% ethanol extract (Production Example 3) 0.10
2. Pineapple fruit 30% ethanol extract (Production Example 5) 1.80
3. 3. Papaya fruit 30% ethanol extract (Production Example 9) 0.01
4. Citric acid 6.00
5. Sucrose 11.00
6. Fragrance 1.00
7. Water 80.09
<Manufacturing method>
Ingredients 1 to 6 are stirred and dissolved in a part of water of ingredient 7. Next, the remaining water of component 7 is added and mixed, and the sterilized product is used as a beverage.
<Usage>
Take 50 mL per day.
処方例6 化粧水
<処方>
成分 含有量(%)
1.グァバ葉30%エタノール抽出物(製造例2) 5.0
2.パイナップル果実エタノール抽出物(製造例6) 5.0
3.パパイヤ果実粉末(製造例7) 5.0
4.グリセリン 5.0
5.ポリオキシエチレンソルビタンモノラウレート 1.5
6.エタノール 5.0
7.防腐剤 0.5
8.水 73.0
<製造方法>
成分1〜7を成分8の水に撹拌溶解する。
<用法>
1日当り2mLを皮膚に塗布する。
Prescription example 6 Toner <Prescription>
Ingredient content (%)
1. 1. Guava leaf 30% ethanol extract (Production Example 2) 5.0
2. Pineapple fruit ethanol extract (Production Example 6) 5.0
3. 3. Papaya fruit powder (Production Example 7) 5.0
4. Glycerin 5.0
5. Polyoxyethylene sorbitan monolaurate 1.5
6. Ethanol 5.0
7. Preservative 0.5
8. Water 73.0
<Manufacturing method>
Ingredients 1 to 7 are stirred and dissolved in the water of ingredient 8.
<Usage>
Apply 2 mL per day to the skin.
比較例1 従来の顆粒剤
処方例1の顆粒剤において、グァバ葉30%エタノール抽出物(製造例2)を乳糖に置換えたものを、従来の顆粒剤とした。
Comparative Example 1 Conventional Granules The granules of Formulation Example 1 in which the guava leaf 30% ethanol extract (Production Example 2) was replaced with lactose were used as the conventional granules.
試験例1 グァバ葉によるPAD1発現促進作用、SMPD1発現促進作用及びASAH1発現抑制作用
DMEM培地でコンフルエントまで培養したヒトケラチノサイトHaCaTに、グァバ葉30%エタノール抽出物(製造例2)を24時間添加して、リアルタイムPCR法によりPAD1の遺伝子発現解析を行い、未添加条件の発現量を1として比較した。また、スフィンゴミエリンホスホジエステラーゼ1(SMPD1、sphingomyelin phosphodiesterase1)、N−アセチルスフィンゴシンアミドヒドロラーゼ1(ASAH1、N−acylsphingosine amidohydrolase1)の遺伝子発現解析を行った。
Test Example 1 PAD1 expression promoting action, SMPD1 expression promoting action and ASAH1 expression suppressing action by Guava leaves To human keratinocyte HaCaT cultured to confluence in DMEM medium, Guava leaf 30% ethanol extract (Production Example 2) was added for 24 hours. , PAD1 gene expression analysis was performed by the real-time PCR method, and the expression level under the non-addition condition was set to 1 for comparison. In addition, gene expression analysis of sphingomyelin phosphodiesterase 1 (SMPD1, sphingomyelin phosphodiesterase 1) and N-acetylsphingosine amide hydrolase 1 (ASAH1, N-acetylsphingosine amidohydrose1) was performed.
PAD1用のプライマーセット
GGGCCCCACTTAGAATTGCT(配列番号1)
GTGCAGATGCAAAGTCATTATCCTT(配列番号2)
SMPD1用のプライマーセット
GAAAGGGTGAAAAAGCCCAAAT(配列番号3)
GGTTCTTTCACCGGATGATCTT(配列番号4)
ASAH1用のプライマーセット
GAATCCAGCACGTCTGTGTGA(配列番号5)
AGGTAGAAGTGAAAAACTGAAGAATGTG(配列番号6)
Primer set for PAD1 GGGCCCCACTTAGAATTGCT (SEQ ID NO: 1)
GTGCAGATGCAAAGTCATTACCTT (SEQ ID NO: 2)
Primer set for SMPD1 GAAAGGGTGAAAAAAGCCCAAAT (SEQ ID NO: 3)
GGTTCTTTCACCGGATGATCTT (SEQ ID NO: 4)
Primer set for ASAH1 GAATCCAGCAGCGTGTGTGA (SEQ ID NO: 5)
AGGTAGAAGTGAAAAAACTGAAGAATAGTG (SEQ ID NO: 6)
試験例1の結果を表1に示す。グァバ葉30%エタノール抽出物(製造例2)は、PAD1の発現を促進した。このことから、グァバ葉のPAD1発現促進作用が示された。また、製造例2のグァバ葉30%エタノール抽出物はSMPD1の発現を促進し、ASAH1の発現を抑制した。 The results of Test Example 1 are shown in Table 1. The guava leaf 30% ethanol extract (Production Example 2) promoted the expression of PAD1. From this, the PAD1 expression promoting action of the guava leaf was shown. In addition, the guava leaf 30% ethanol extract of Production Example 2 promoted the expression of SMPD1 and suppressed the expression of ASAH1.
グァバ葉30%エタノール抽出物(製造例2)は、保湿において重要なPAD1の発現を促進したことから、グァバ葉は保湿作用を有している。 Since the guava leaf 30% ethanol extract (Production Example 2) promoted the expression of PAD1, which is important in moisturizing, the guava leaf has a moisturizing effect.
グァバ葉30%エタノール抽出物(製造例2)は、毛の発生と伸長において重要なPAD1の発現を促進したことから、グァバ葉は発毛及び育毛作用を有している。 Since the guava leaf 30% ethanol extract (Production Example 2) promoted the expression of PAD1, which is important for hair development and elongation, the guava leaf has a hair growth and hair growth effect.
試験例2 グァバ葉、パイナップル果実、パパイヤ果実によるPAD1発現促進作用
DMEM培地でコンフルエントまで培養したヒトケラチノサイトHaCaTに、グァバ葉30%エタノール抽出物(製造例2)、パイナップル果実エタノール抽出物(製造例6)、パパイヤ果実粉末(製造例7)を24時間添加して、リアルタイムPCR法による遺伝子発現解析を行った。プライマーは試験例1と同じものを用い、未添加の条件での発現量を1として比較した。
Test Example 2 PAD1 expression promoting action by guava leaves, pineapple fruits, and papaya fruits To human keratinocytes HaCaT cultured to confluence in DMEM medium, guava leaves 30% ethanol extract (Production Example 2), pineapple fruit ethanol extract (Production Example 6) ), Pineapple fruit powder (Production Example 7) was added for 24 hours, and gene expression analysis was performed by the real-time PCR method. The same primer as in Test Example 1 was used, and the expression level under the condition of no addition was set to 1 for comparison.
試験例2の結果を表2に示す。グァバ葉30%エタノール抽出物(製造例2)、パイナップル果実エタノール抽出物(製造例6)、パパイヤ果実粉末(製造例7)を各々添加した場合と比較して、製造例2、6、7の併用はPAD1発現量の大幅な増加を示した。このことから、グァバ葉、パイナップル果実、パパイヤ果実の併用は格別顕著なPAD1発現促進効果を示し、優れた保湿作用、発毛及び育毛作用を有している。 The results of Test Example 2 are shown in Table 2. Compared with the case where 30% ethanol extract of guaba leaf (Production Example 2), pineapple fruit ethanol extract (Production Example 6), and papaya fruit powder (Production Example 7) were added, Production Examples 2, 6 and 7 were added. The combination showed a significant increase in PAD1 expression level. From this, the combined use of guava leaf, pineapple fruit, and papaya fruit shows a particularly remarkable PAD1 expression promoting effect, and has an excellent moisturizing effect, hair growth, and hair growth effect.
試験例3 ヒト飲用による保湿作用
男女104名(20〜50歳代)を26人ずつ4群に分け、グァバ葉を含有する顆粒剤(処方例1)、グァバ葉、パイナップル果実、パパイヤ果実を含有する顆粒剤(処方例2)、グァバ葉、パイナップル果実、パパイヤ果実、β―カロテン、ビタミンC、ビタミンEを含有する顆粒剤(処方例3)、従来の顆粒剤(比較例1)を、1回1.6gを1日2回、3ヶ月間飲用させた。保湿作用の評価は、コルネオメーターを用いた角質水分量の測定とテヴァメーターを用いた水分蒸散量の測定を行い、飲用前を100%とした時の飲用後の角質水分量、水分蒸散量を比較した。
Test Example 3 Moisturizing effect by human drinking 104 males and females (20s to 50s) were divided into 4 groups of 26 each, and contained guava leaf-containing granules (prescription example 1), guava leaves, pineapple fruit, and papaya fruit. Granules (formulation example 2), guava leaves, pineapple fruit, papaya fruit, β-carotene, vitamin C, vitamin E-containing granules (formulation example 3), conventional granules (comparative example 1), 1 1.6 g of the dose was drunk twice a day for 3 months. To evaluate the moisturizing effect, the keratin water content was measured using a corneometer and the water evaporation amount was measured using a tevameter. Compared.
試験例3の結果を表3に示す。グァバ葉を含有する顆粒剤(処方例1)の飲用は、角質水分量増加と水分蒸散量減少を示した。よって、グァバ葉の保湿作用が示された。 The results of Test Example 3 are shown in Table 3. Drinking of granules containing guava leaves (Prescription Example 1) showed an increase in keratin water content and a decrease in water evaporation amount. Therefore, the moisturizing effect of guava leaves was shown.
グァバ葉、パイナップル果実、パパイヤ果実を含有する顆粒剤(処方例2)の飲用は、処方例1の飲用よりも著しい角質水分量増加と水分蒸散量減少を示した。よって、グァバ葉、パイナップル果実、パパイヤ果実の併用による優れた保湿作用が示された。 Drinking of the granule (Prescription Example 2) containing guava leaves, pineapple fruit, and papaya fruit showed a remarkable increase in keratin water content and a decrease in water evaporation amount as compared with the drinking of Formulation Example 1. Therefore, the combined use of guava leaves, pineapple fruits, and papaya fruits showed an excellent moisturizing effect.
また、処方例1、処方例2及び処方例3の飲用は、角質水分量増加と水分蒸散量減少だけでなく、踵、足首、脛、肘などの身体の乾燥やカサつきの改善を示した。 In addition, drinking of Formulation Example 1, Formulation Example 2 and Formulation Example 3 showed not only an increase in keratin water content and a decrease in water evaporation amount, but also an improvement in dryness and dryness of the body such as heels, ankles, shins and elbows.
試験例4 ヒト飲用による発毛及び育毛作用
男女104名(20〜50歳代)を26人ずつ4群に分け、グァバ葉を含有する顆粒剤(処方例1)、グァバ葉、パイナップル果実、パパイヤ果実を含有する顆粒剤(処方例2)、グァバ葉、パイナップル果実、パパイヤ果実、β―カロテン、ビタミンC、ビタミンEを含有する顆粒剤(処方例3)、従来の顆粒剤(比較例1)を用いて、1回1.6gを1日2回、6ヶ月間飲用させた。発毛及び育毛作用の評価は、飲用前に刈毛(1cm×1cm、側頭部の頭髪を根元からハサミを用いて切る)し、写真撮影を行い、毛の本数を写真の画像から計数した。飲用終了後、刈毛(1cm×1cm、側頭部の頭髪を根元からハサミを用いて切る)し、写真撮影を行い、毛の本数と毛の長さを写真の画像から計測した。2日後、写真撮影を行い、毛の長さを計測した。毛の伸長率は、飲用終了後の2日間で伸長した毛の長さを、比較例1の顆粒剤の飲用で伸長した毛の長さを100とした時の百分率で算出した。毛の本数の増加率は、各顆粒剤で飲用前の毛の本数を100とした時の、各顆粒剤の飲用終了後の毛の本数を、飲用前と比べた割合で示した。
Test Example 4 Hair growth and hair growth effect by human drinking 104 males and females (20s to 50s) were divided into 4 groups of 26 each, and granules containing guava leaves (prescription example 1), guava leaves, pineapple fruits, papaya Fruit-containing granules (prescription example 2), guava leaves, pineapple fruits, papaya fruits, β-carotene, vitamin C, vitamin E-containing granules (formulation example 3), conventional granules (comparative example 1) 1.6 g of guava was drunk twice a day for 6 months. To evaluate the hair growth and hair growth effect, hair was cut (1 cm x 1 cm, the hair on the temporal region was cut with scissors from the root) before drinking, and a photograph was taken, and the number of hairs was counted from the image of the photograph. .. After the end of drinking, the hair was cut (1 cm × 1 cm, the hair on the temporal region was cut from the root with scissors), a photograph was taken, and the number of hairs and the length of the hairs were measured from the image of the photograph. Two days later, a photograph was taken and the length of the hair was measured. The hair elongation rate was calculated as a percentage of the length of the hair elongated in 2 days after the end of drinking, when the length of the hair elongated by drinking the granule of Comparative Example 1 was set to 100. The rate of increase in the number of hairs was shown as a ratio of the number of hairs after drinking of each granule as compared with that before drinking, when the number of hairs before drinking was 100 for each granule.
試験例4の結果を表4に示す。グァバ葉を含有する顆粒剤(処方例1)の飲用は、毛の伸長率と毛の本数の増加率が向上した。よって、グァバ葉の発毛及び育毛作用が示された。 The results of Test Example 4 are shown in Table 4. Drinking of granules containing guava leaves (Prescription Example 1) improved the rate of hair elongation and the rate of increase in the number of hairs. Therefore, the hair growth and hair growth effects of guava leaves were shown.
グァバ葉、パイナップル果実、パパイヤ果実を含有する顆粒剤(処方例2)の飲用は、処方例1の飲用よりも著しい毛の伸長率と毛の本数の増加率を示した。よって、グァバ葉、パイナップル果実、パパイヤ果実の併用による優れた発毛及び育毛作用が示された。 Drinking of granules containing guava leaves, pineapple fruits, and papaya fruits (Prescription Example 2) showed a remarkable rate of hair elongation and a rate of increase in the number of hairs as compared with the drinking of Formulation Example 1. Therefore, the combined use of guava leaves, pineapple fruits, and papaya fruits showed excellent hair growth and hair growth effects.
以上の結果より、グァバ葉のPAD1発現促進作用、保湿作用、発毛及び育毛作用が示された。また、グァバ葉、パイナップル果実、パパイヤ果実の併用により優れたPAD1発現促進作用、保湿作用、発毛及び育毛作用が示された。 From the above results, the PAD1 expression promoting action, the moisturizing action, the hair growth and the hair growth action of the guava leaf were shown. In addition, the combined use of guava leaves, pineapple fruits, and papaya fruits showed excellent PAD1 expression promoting action, moisturizing action, hair growth and hair growth action.
本発明のPAD1発現促進剤は、優れたPAD1発現促進作用、保湿作用、発毛及び育毛作用を示した。従って、優れたPAD1発現促進作用、保湿作用、発毛及び育毛作用を有する食品、医薬部外品又は医薬品としての利用に有用である。また、皮膚外用剤としても利用可能である。 The PAD1 expression-promoting agent of the present invention exhibited excellent PAD1 expression-promoting action, moisturizing action, hair growth and hair growth action. Therefore, it is useful for use as a food, quasi-drug, or pharmaceutical product having an excellent PAD1 expression promoting effect, moisturizing effect, hair growth and hair growth effect. It can also be used as an external preparation for the skin.
Claims (5)
A food composition for promoting PAD1 expression, moisturizing or hair growth, and hair growth, containing the PAD1 expression promoting agent according to claim 1 or 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020006711A JP7479038B2 (en) | 2020-01-20 | 2020-01-20 | Peptidylarginine deiminase 1 expression promoter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020006711A JP7479038B2 (en) | 2020-01-20 | 2020-01-20 | Peptidylarginine deiminase 1 expression promoter |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021113172A true JP2021113172A (en) | 2021-08-05 |
JP7479038B2 JP7479038B2 (en) | 2024-05-08 |
Family
ID=77076585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020006711A Active JP7479038B2 (en) | 2020-01-20 | 2020-01-20 | Peptidylarginine deiminase 1 expression promoter |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7479038B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023112717A1 (en) * | 2021-12-17 | 2023-06-22 | 株式会社 資生堂 | Pad1 production-promoting drug and novel drug evaluation method |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4143223B2 (en) | 1999-07-30 | 2008-09-03 | 一丸ファルコス株式会社 | Cosmetic composition containing moisturizing plant extract |
JP3658546B2 (en) | 2001-05-11 | 2005-06-08 | パーソナルコスメディック株式会社 | Testosterone 5α-reductase inhibitor and hair nourishing agent |
JP5714869B2 (en) | 2010-10-29 | 2015-05-07 | 丸善製薬株式会社 | Sugar-free pineapple extract, method for producing the same, and use thereof |
JP6204019B2 (en) | 2013-01-09 | 2017-09-27 | 花王株式会社 | CGI-58 expression promoter |
JP6704628B2 (en) | 2014-02-18 | 2020-06-03 | 共栄化学工業株式会社 | Cosmetics |
-
2020
- 2020-01-20 JP JP2020006711A patent/JP7479038B2/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023112717A1 (en) * | 2021-12-17 | 2023-06-22 | 株式会社 資生堂 | Pad1 production-promoting drug and novel drug evaluation method |
Also Published As
Publication number | Publication date |
---|---|
JP7479038B2 (en) | 2024-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4693963B2 (en) | Estrogen-like agent, collagen production promoter, and fibroblast proliferating agent | |
JP2003300858A (en) | Skin care preparation | |
JP2000191498A (en) | Collagen production facilitative agent and preparation for external use for skin | |
JPH09328410A (en) | Cosmetic and its production | |
EP0977550B1 (en) | Use of at least one irvingia gabonensis extract in a cosmetic and/or pharmaceutical product | |
JP2004346045A (en) | Cosmetic additive, bathing agent and health food containing sake lees extract obtained in brewing of sake using deep seawater | |
JP3263409B2 (en) | External preparation for skin | |
JP2021113172A (en) | Peptidyl arginine deiminase 1 expression promoter | |
JP5888563B2 (en) | Moisturizer, rough skin improving agent, stratum corneum moisture increasing agent, blood flow improving agent and skin dullness, bear or gloss improving agent | |
JP5312733B2 (en) | Moisturizer, cell activator, antioxidant, protease activity promoter, anti-aging agent, whitening agent, anti-inflammatory agent, neutral fat accumulation inhibitor | |
JP2002284632A (en) | Extinction substance for superoxide anion extracted from sake lees as effective component | |
JP2012051837A (en) | Glutathione production promoter | |
JP2012162487A (en) | Whitening agent, anti-aging agent and skin cosmetic | |
JP4247091B2 (en) | Skin anti-aging agent | |
JPH09315930A (en) | Cosmetic material for skin | |
JP2000212058A (en) | Skin cosmetic, active oxygen eliminator, esterase inhibitor, and collagenase inhibitor | |
JP2004149729A (en) | Antioxidant | |
JP4222973B2 (en) | Elastase activity inhibitors and cosmetics | |
JP5247548B2 (en) | Moisturizer, anti-aging agent, neutral fat accumulation inhibitor, whitening agent, anti-inflammatory agent, topical skin preparation, oral preparation | |
JP2008303180A (en) | Skin-lightening agent, skincare preparation for external use, and functional oral composition | |
JP5610681B2 (en) | Neutral fat accumulation inhibitor | |
JP2006282536A (en) | Super oxide-eliminating agent, free radical-eliminating agent, hydrogen peroxide-eliminating agent and external preparation for skin | |
JP2020002053A (en) | Collagen production promoter, MMP inhibitor, melanin production inhibitor, cell growth promoter, antioxidant, wrinkle improver, pharmaceutical or food composition | |
JP4748962B2 (en) | Moisturizer, cell activator, whitening agent, and antioxidant | |
JP2004224789A (en) | Fat decomposition accelerator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221130 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231010 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231122 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240109 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240402 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240416 |